Family Medicine · Ripley, MS
NPI
1023529443
Since 2017
Specialty
Family Medicine
Code 207Q00000X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
1005a City Ave N
Ripley, MS, 38663
Phone (662) 837-9221
Groups this clinician bills Medicare through
Medicare paid, 2023
$5,898
569 services
Medicare patients, 2023
258
Average age 72
Drug cost, 2024
$8.6M
10,392 prescriptions
Company payments, 2025
$774
From 13 companies
Procedures and visits billed to Original Medicare, 2023
In 2023, the most common Medicare service billed by Alisha Mason was code 83036 (blood count), 389 times for 237 patients. In total Alisha Mason billed 569 services in 24 codes, and Medicare paid $5,898.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2017-10-12.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 83036 Blood Count | Office | 389 | 237 | $9.48 | $3,687 |
| 81003 Clinical Chemistry | Office | 49 | 47 | $2.20 | $108 |
| 82043 Clinical Chemistry | Office | 28 | 28 | $5.66 | $158 |
| 82570 Clinical Chemistry | Office | 28 | 28 | $5.08 | $142 |
By year: 2022 $12K for 1,056 services; 2023 $5,898 for 569 services.
Lab tests billed to Medicare, 2023
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 83036 Blood Count | 389 | 237 | $9.48 | $3,687 |
| 81003 Clinical Chemistry | 49 | 47 | $2.20 | $108 |
| 82043 Clinical Chemistry | 28 | 28 | $5.66 | $158 |
| 82570 Clinical Chemistry | 28 | 28 | $5.08 | $142 |
Medicare prescription drug claims, 2024
In 2024, the drug Alisha Mason prescribed most often to Medicare patients was Ozempic (Semaglutide), with 724 prescriptions and refills. In total Alisha Mason wrote 10,392 Medicare prescriptions that cost $8.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Ozempic Semaglutide | 724 | 1,967 | 280 | $1.9M |
| Eliquis Apixaban | 553 | 1,643 | 211 | $936K |
| Farxiga Dapagliflozin Propanediol | 524 | 1,549 | 207 | $848K |
| Mounjaro Tirzepatide | 375 | 702 | 106 | $747K |
| Jardiance Empagliflozin | 306 | 873 | 114 | $498K |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 301 | 875 | 123 | $538K |
| Xarelto Rivaroxaban | 295 | 865 | 108 | $455K |
| Atorvastatin Calcium Generic | 273 | 802 | 121 | $2,138 |
| Tresiba Flextouch U-100 Insulin Degludec | 184 | 521 | 82 | $220K |
| Rosuvastatin Calcium Generic | 177 | 512 | 83 | $1,851 |
| Omeprazole Generic | 170 | 484 | 77 | $1,491 |
| Gabapentin Generic | 170 | 433 | 79 | $3,399 |
| Lisinopril Generic | 167 | 497 | 76 | $955 |
| Ezetimibe Generic | 163 | 437 | 71 | $2,409 |
| Amlodipine Besylate Generic | 162 | 459 | 75 | $493 |
Brand drugs: 5,365 claims; generic drugs: 4,909 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Alisha Mason $774 ($774 in general payments such as food, travel and fees) from 13 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $152.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 8 | $152 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 5 | $82.17 |
| Novo Nordisk Inc NVO | 5 | $78.84 |
| Esperion Therapeutics, Inc. ESPR | 4 | $72.34 |
| Amgen Inc. AMGN | 4 | $64.52 |
| Lilly USA, LLC LLY | 4 | $64.45 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) JNJ | 3 | $60.12 |
| Sumitomo Pharma America, Inc. 4506.T | 3 | $54.52 |
| GlaxoSmithKline, LLC. GSK | 2 | $44.06 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $38.12 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.